® Registered trademark of Novo Nordisk A/S.
© Copyright 2016.Sponsored by Novo Nordisk Pharmaceuticals Pty Ltd. ABN 40 002 879 996.Level 3, 21 Solent Circuit, Baulkham Hills, NSW Australia 2153. www.novonordisk.com.au. Novo Nordisk Pharmaceuticals Limited.Company No. 481 264. 58 Richard Pearse Dr, Mangere, Auckland New Zealand 2022. www.novonordisk.co.nz. AU/CD/0517/0318(2). Date of preparation: April 2018. ZEST/NORSY067/0418
The Changing Diabetes Map is an interactive web-based tool which displays summarised average HbA1c data from different geographic regions within Australia. The HbA1c data is accessed through the "Mapping Glycaemic Control Across Australia" project, which collects national HbA1cdata. This project addresses the need for HbA1c data which has previously been lacking in the primary care setting.
The "Mapping Glycaemic Control Across Australia" project has been possible through the unrestricted funding support and partnership of Novo Nordisk, and the support and assistance of Sullivan Nicolaides Pathology, Central Queensland Pathology Laboratory, Barratt & Smith Pathology, Douglas Hanly Moir Pathology, Southern.IML Pathology, Capital Pathology, Melbourne Pathology, Hobart Pathology, Launceston Pathology, North West Pathology, Clinpath Laboratories, QML and Western Diagnostic Pathology.
The Changing Diabetes® Map allows for the observation of trends and no statistical conclusion can be drawn. The intent of providing this material is informational and not as advice.
The information you are about to access may not comply with the Australian or New Zealand regulatory environment.
Do you still want to proceed?
The information you are about to access may not comply with the Australian regulatory environment. Please review the Approved Product Information to understand the terms of a product’s registration in Australia. For further information relevant to the Australian environment, please contact Novo Nordisk. The linked information is educational only and not intended as advice. Any information provided should be discussed with a healthcare professional and does not replace their advice.
The purpose of this policy is to:
Novo Nordisk believes that choice is one of the most important privacy principles. You will always have a choice as to what information you provide and we will give you the right to be anonymous in your dealings with us wherever possible. However, if you decide to withhold personal information which is necessary for us to provide a product or service, it may affect our ability to provide you with that product or service.
The information we collect about you will vary depending upon our dealings with you, however Novo Nordisk will only ask for information where there is a clear need and it is reasonably necessary for our functions or activities.
Generally, Novo Nordisk collects information for one or more of the following purposes:
In addition, Novo Nordisk may gather information about you automatically through your use of our website (e.g. your Internet Protocol (“IP”) address) and how you navigate our website. See also the sections below on “Using our Website” and “About Cookies”.
We will usually only collect your personal information from you or an authorised representative.
Novo Nordisk will only use personal information for purposes which are directly related to one of our business functions or activities and for: the primary purpose for which it was given to us; or, to the extent:
Indicated to you at the time of supply of the information to us;
As a general practice , we require that Novo Nordisk’s third party service providers who handle and obtain personal information comply with: this Policy; the relevant Australian and New Zealand Acts and Regulations (as amended from time to time) – and are subject to obligations to treat this information as confidential information.
We do not sell, rent, or trade your personal information with others. Information provided by you may be stored in databases or other systems which are stored overseas including, but not limited to Australia, New Zealand, Denmark and India.
Novo Nordisk may transfer your de-identified personal and health information to an associated company in USA and/or Europe for the specific purpose of reporting adverse events. We will ensure we comply with our obligations under the respective Privacy Principles with respect to that transfer.
We impose obligations on any external organisations with which we share your personal information to maintain the integrity and security of that information.
We may disclose your personal information in the following circumstances:
Forms used to collect your information may give more specific details about the way we use your information.
We take all reasonable steps to protect your personal information from misuse, loss, unauthorised access, modification or disclosure. Your information is stored securely whether in an electronic or physical form. For example, only staff needing access to the information are allowed access. Your personal information is stored in secured premises or in electronic databases requiring logins and passwords.
Some information is kept for a number of years to comply with legal requirements. Any personal information that is no longer needed is de-identified or destroyed.
In our dealings involving some consumers we use a unique "H" number assigned by the Australian Department of Health and Ageing to each government-approved patient who receives human growth hormone. We are required to use and disclose the H number consistently with the relevant legislative requirements (contained in the National Health (Growth Hormone Program) Special Arrangement issued under the National Health Act) in our capacity as a "responsible person" under those arrangements.
We collect general usage information about visitors coming to our website. This includes:
You cannot be identified from this information.
Sometimes our web servers collect this general information (referred to above) with the help of cookies. A cookie is a small file that a Web site writes to your hard drive when you visit that website. Cookies cannot read information from your hard drive or read information from other cookies.
You can always seek access to your personal information and ask us to correct or delete any inaccurate, incomplete or out of date information. Contact us at the contact address below if you want access to, or want to correct, or make a complaint in relation to the personal information we hold about you. One of our representatives will contact you in relation to your request or complaint.
We are required to take reasonable steps to correct information we hold, to ensure it is accurate, up to date, relevant and not misleading, having regard for the purposes for which it is held.
We are required to take reasonable steps to correct faulty information:
There is no fee for requesting access to your information. However, we may charge you the reasonable cost of processing your request and there may be some legal or administrative reasons to deny access. If we decide to deny access, we will provide you with a reason why.
You may review, change, or correct any personal information including the permitted uses of your personal information by contacting Novo Nordisk at the relevant address below.
Novo Nordisk Pharmaceuticals Pty. Ltd.
Attn: Privacy Officer
PO Box 7586
Baulkham Hills BC NSW 2153
In New Zealand:
Novo Nordisk Pharmaceuticals Limited
Attn: Privacy Officer
PO Box 51268
+ Copyright: Novo Nordisk A/S, 2016
Novo Nordisk disclaims any and all liability related to or arising out of use of the information contained in this website.
Welcome to the Changing Diabetes Website.
The information provided on this website is for general information and educational purposes only. This website may, from time to time, contain information relating to various medical conditions and their treatment. The product related information on this website is not medical advice and should not be relied upon by any particular individual or for any specific purpose. Any medical questions should be referred to your healthcare professional. It is important that you rely only on the advice of a health care professional to advise you on your specific situation.
This website is available only for your personal, non-commercial use. You may not copy, reproduce, republish, post, distribute, transmit or modify in any way all or any part of this website.
All copyright and other proprietary notices contained in downloaded materials must be preserved and retained. All contents of this website are copyrighted work of Novo Nordisk and/or any of Novo Nordisk's suppliers or affiliates unless otherwise noted, and may not be used without the express written permission of Novo Nordisk or except as provided herein.
Images of people or places displayed on this website are either the property of, or used with permission by, Novo Nordisk. The use of these images by you is strictly prohibited.
Novo Nordisk offers products and services to diagnose, prevent and treat disease. Our prescription medicines for use by healthcare professionals are regulated by government agencies in each of the countries in which we do business, such as: the Therapeutic Goods Administration in Australia; Medsafe (the New Zealand Medicines and Medical Devices Safety Authority); and, the Food and Drug Administration in the United States. Regulations often restrict the prescribing information that can be disclosed to the public thus requiring personal consultation with your healthcare professional.
Under no circumstances will Novo Nordisk or any other company within the Novo Nordisk Group of Companies be liable for any indirect, incidental, special and/or consequential damage or loss of profits which result from any use or access of, or any inability to use or access, this website or any content.
Novo Nordisk collects personally identifiable information (i.e. information from which you can be identified, such as name, address, telephone number or e-mail address) only when it is asked for and/or you voluntarily submit it to us. While you do not have to provide this information a failure to do so may mean that we are unable to provide you with information or services from this website.
This website may link to other websites, some of which are outside Australia. Those websites may have information that is appropriate only to the particular originating country or region where the website is based. You should not construe anything on this website as a promotion or solicitation for any product or for the use of any product that is not authorised by the laws and regulations of the country where you are located. Novo Nordisk makes no representation that materials in this website are appropriate or available for use in other locations. Those who choose to access this website from other locations do so on their own initiative and are responsible for compliance with local laws, if and to the extent local laws are applicable.
Software from this website is further subject to United States export controls. No software from this website may be downloaded or otherwise exported or re-exported (i) into (or to a national or resident of) Cuba, Iraq, Libya, North Korea, Iran, Syria or any other country subject to United States export control restrictions; or (ii) to anyone on the U.S. Treasury Department’s list of Specially Designated Nationals or the U.S. Commerce Department’s Table of Denial Orders. By downloading or using the Software, you represent and warrant that you are not located in, under the control of, or a national or resident of any such country or on any such list.
You agree that you will not use any robot, spider or other automatic or manual process or device to “Screen scrape”, monitor, “mine”, or copy web pages of this website, or the content contained therein, without Novo Nordisk’s express consent. You also agree that you will not use any device, software or routine in an attempt to interfere with the proper operation of this website. You will not spam any user of this website for any reason. You will not do anything that puts an unreasonably large load on Novo Nordisk’s infrastructure. Any access or attempt to access other areas of Novo Nordisk’s computer system, or any information on its systems is strictly prohibited.
Novo Nordisk collects non-personally identifiable information in aggregate form to track data such as the total number of visits to our website, the number of visitors to each page of our website, the general geographical areas from where those visitors accessed our website and the domain names of our visitors' internet service providers. We use this information, which remains in aggregate form, to understand how our visitors use our website so that we may improve them and the services we offer. We may also share this information with other companies within the Novo Nordisk group and with other third parties. No personally identifiable information is disclosed in this process.
An Internet Protocol (IP) address is a set of numbers that is automatically assigned to your computer whenever you log on to your internet service provider or through your organisation's local area network (LAN) or wide area network (WAN). Web servers automatically identify your computer by the IP address assigned to it during your session online.
Certain links on this website lead to resources located on servers that are not maintained by Novo Nordisk or under its control. We provide such links merely for our users' convenience. Novo Nordisk is not responsible for the content of any such referenced websites or for the availability of access to such websites. Inclusion on this website of any link to another website, or any reference to any product or service by trade name, trademark, manufacturer, or otherwise, does not constitute or imply an endorsement or recommendation of such by Novo Nordisk. Access to other websites linked to this website is at your own risk, and to the extent permitted by law we disclaim all liability with regard to your access to such linked websites.
*A dispensing fee may be charged at some pharmacies.
NYHA: New York Heart Association